H. Finke

Biography

Lothar H. Finke joined Incyte in June 2017 as General Manager of Incyte Japan, establishing the Company’s corporate presence in Asia. Dr. Finke joined Incyte with over 20 years of biotech and pharmaceutical industry experience in roles of increasing responsibility at Merck KGaA, Argos Therapeutics and Novartis Oncology with assignments in Europe, North America and Asia. Prior to joining Incyte, Dr. Finke most recently led clinical development and medical affairs for Novartis Pharma KK’s oncology-hematology portfolio at their head office in Tokyo. Dr. Finke’s clinical background is in surgical oncology, having earned a medical degree and doctorate degree in cell biology from the University of Marburg, Germany. Lothar H. Finke joined Incyte in June 2017 as General Manager of Incyte Japan, establishing the Company’s corporate presence in Asia. Dr. Finke joined Incyte with over 20 years of biotech and pharmaceutical industry experience in roles of increasing responsibility at Merck KGaA, Argos Therapeutics and Novartis Oncology with assignments in Europe, North America and Asia. Prior to joining Incyte, Dr. Finke most recently led clinical development and medical affairs for Novartis Pharma KK’s oncology-hematology portfolio at their head office in Tokyo. Dr. Finke’s clinical background is in surgical oncology, having earned a medical degree and doctorate degree in cell biology from the University of Marburg, Germany.

Research Interest

Oncology